FATE THERAPEUTICS INC (FATE) Cash flow
Market cap
$135.27M
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 3 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 6 | 14 | 18 | 19 |
| Stock-based compensation | 2 | 2 | 2 | 3 | 4 | 6 | 17 | 31 | 54 | 79 | 43 | 41 |
| Cash from operations | -15 | -22 | -18 | -30 | -37 | -39 | -83 | -39 | -163 | -248 | -132 | -123 |
| Capital expenditures | -4 | -1 | -1 | -0 | -2 | -2 | -7 | -5 | -51 | -36 | -6 | -1 |
| Cash from investing | -0 | -1 | -1 | -4 | -10 | -0 | -157 | -161 | -324 | 167 | 113 | 12 |
| Repurchases of common stock | 0 | - | - | - | - | - | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | 6 | 20 | - | - | 15 | - | - | - | - | - | - | - |
| Repayments of term debt | 5 | 2 | 2 | 8 | 11 | - | 15 | - | - | - | - | - |
| Cash from financing | 132 | 18 | 36 | 58 | 47 | 141 | 150 | 283 | 453 | 9 | 0 | 100 |
| Free cash flow | ||||||||||||
| FCF margin (%) | - | - | - |